# Tango Therapeutics, Inc. (TNGX): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/tngx for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Tango Therapeutics, Inc. is a biotechnology firm dedicated to the research and development of innovative cancer treatments. Their primary therapeutic candidate, TNG908, is a synthetic lethal small molecule designed to inhibit protein arginine methyltransferase 5 (PRMT5). This compound is currently being advanced as a potential therapy for cancers characterized by methylthioadenosine phosphorylase (MTAP) deletions. Additionally, their pipeline includes an Ubiquitin-specific protease 1 (USP1) inhibitor targeting BRCA1 or BRCA2-mutant cancers, and a program known as 'Target 3' which addresses...

## Quote & Key Metrics

As of 2026-10-26:

| Metric | Value |
|---|---|
| Price | $23.45 USD |
| Market Cap | $3.95B |
| P/E (TTM) | — |
| EPS (TTM) | −$0.85 |
| 52-Week Range | $7.12 – $34.39 |
| Dividend Yield (TTM) | — |

## Dividend

TNGX has no dividend payment history in our records.

## Frequently Asked Questions

### What does Tango Therapeutics, Inc. do?

Tango Therapeutics, Inc. (TNGX) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is TNGX's market cap?

Tango Therapeutics, Inc. (TNGX) has a market capitalization of approximately $3.95 billion, as of October 26, 2026, based on the most recent share price and shares outstanding.

### Does TNGX pay a dividend?

No, Tango Therapeutics, Inc. (TNGX) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is TNGX profitable?

Tango Therapeutics, Inc. (TNGX) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has TNGX ever paid a dividend?

No. Dividend Data's records show no dividend payments from Tango Therapeutics, Inc. (TNGX). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/tngx
- Dividend history & safety: https://www.dividenddata.com/stocks/tngx/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/tngx/earnings
- Financial statements: https://www.dividenddata.com/stocks/tngx/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/tngx/valuation
- Peer comparison: https://www.dividenddata.com/stocks/tngx/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.